Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02055105

Modulation of Molecular Fingerprinting in Pediatric Sepsis

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Phoenix Children's Hospital · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.

Detailed description

This study will aid in the evaluation of determining the accuracy of these miRNAs in pediatric patients and help in establishing pilot data for additional studies in the future. The testing will include blood samples, urine samples and buccal swabs from patients who meet eligibility at 5 time points to analyze biomarkers. Study participants will receive standard of care with antimicrobials and any additional appropriate cardiovascular or respiratory support per the clinical team. The samples will collected and stored at -80 until analysis can be performed. In addition to, during the course of the hospitalization, the enrolled patient will have data collected to calculate severity scores, including updated Pediatric Risk of Mortality (PRISM III) scores and simplified Therapeutic Intervention Scoring System(TISS-28) scores. All patient information will be de-identified. A standard procedure manual will be developed detailing the methods for data collection and entry. Data will be recorded in a de-identified manner on a Microsoft Excel database on a secure institutional server by the institutional staff. Data will then be analyzed to determine correlation of biomarkers to morbidity and mortality for these patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREmiRNA in SepsismiRNA in Sepsis

Timeline

Start date
2014-03-01
Primary completion
2027-06-01
Completion
2027-10-01
First posted
2014-02-04
Last updated
2025-11-12

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02055105. Inclusion in this directory is not an endorsement.